Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome

被引:119
作者
Nelson-Degrave, VL
Wickenheisser, JK
Hendricks, KL
Asano, T
Fujishiro, M
Legro, RS
Kimball, SR
Strauss, JF
McAllister, JM
机构
[1] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA
[2] Penn State Univ, Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA
[3] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab, Bunkyo Ku, Tokyo 1138655, Japan
[4] Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA
关键词
D O I
10.1210/me.2004-0178
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have investigated the involvement of the MAPK signaling pathway in increased androgen biosynthesis and CYP17 gene expression in women with polycystic ovary syndrome ( PCOS). A comparison of MAPK kinase (MEK1/2) and ERK1/2 phosphorylation in propagated normal and PCOS theca cells, revealed that MEK1/2 phosphorylation was decreased more than 70%, and ERK1/2 phosphorylation was reduced 50% in PCOS cells as compared with normal cells. Infection with dominant-negative MEK1 increased CYP17 mRNA and dehydroepiandrosterone ( DHEA) abundance, whereas constitutively active MEK1 reduced DHEA production and CYP17 mRNA abundance. Similarly, the MEK inhibitor, PD98059, increased CYP17 mRNA accumulation and CYP17 promoter activity to levels observed in PCOS cells. Remarkably, in theca cells maintained in the complete absence of insulin, ERK1/2 phosphorylation was decreased in PCOS theca cells as compared with normal theca cells, and CYP17 mRNA and DHEA synthesis were increased in PCOS theca cells. These studies demonstrate that in PCOS cells reduced levels of activated MEK1/2 and ERK1/2 are correlated with increased androgen production, irrespective of the insulin concentration. These findings implicate alterations in the MAPK pathway in the pathogenesis of excessive ovarian androgen production in PCOS.
引用
收藏
页码:379 / 390
页数:12
相关论文
共 70 条
[1]   CHIRO-INOSITOL DEFICIENCY AND INSULIN-RESISTANCE - A COMPARISON OF THE CHIRO-INOSITOL-CONTAINING AND THE MYO-INOSITOL-CONTAINING INSULIN MEDIATORS ISOLATED FROM URINE, HEMODIALYSATE, AND MUSCLE OF CONTROL AND TYPE-II DIABETIC SUBJECTS [J].
ASPLIN, I ;
GALASKO, G ;
LARNER, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) :5924-5928
[2]   Metformin therapy increases insulin-stimulated release of D-chiro-inositol-containing inositolphosphoglycan mediator in women with polycystic ovary syndrome [J].
Baillargeon, JP ;
Iuorno, MJ ;
Jakubowicz, DJ ;
Apridonidze, T ;
He, N ;
Nestler, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (01) :242-249
[3]   INSULIN STIMULATES ANDROGEN ACCUMULATION IN INCUBATIONS OF OVARIAN STROMA OBTAINED FROM WOMEN WITH HYPERANDROGENISM [J].
BARBIERI, RL ;
MAKRIS, A ;
RANDALL, RW ;
DANIELS, G ;
KISTNER, RW ;
RYAN, KJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :904-910
[4]   Altered regulation of insulin signaling components in adipocytes of insulin-resistant type II diabetic Goto-Kakizaki rats [J].
Begum, N ;
Ragolia, L .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (01) :54-62
[5]   Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: Activation of janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/akt pathways [J].
Carvalho, CRO ;
Carvalheira, JBC ;
Lima, MHM ;
Zimmerman, SF ;
Caperuto, LC ;
Amanso, A ;
Gasparetti, AL ;
Meneghetti, V ;
Zimmerman, LF ;
Velloso, LA ;
Saad, MJA .
ENDOCRINOLOGY, 2003, 144 (02) :638-647
[6]  
Ciaraldi TP, 2000, J PEDIATR ENDOCR MET, V13, P1291
[7]   CELLULAR MECHANISMS OF INSULIN RESISTANCE IN POLYCYSTIC OVARIAN SYNDROME [J].
CIARALDI, TP ;
ELROEIY, A ;
MADAR, Z ;
REICHART, D ;
OLEFSKY, JM ;
YEN, SSC .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (02) :577-583
[8]   Enhanced granulosa cell responsiveness to follicle-stimulating hormone during insulin infusion in women with polycystic ovary syndrome treated with pioglitazone [J].
Coffler, MS ;
Patel, K ;
Dahan, MH ;
Yoo, RY ;
Malcom, PJ ;
Chang, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) :5624-5631
[9]   Evidence for abnormal granulosa cell responsiveness to follicle-stimulating hormone in women with polycystic ovary syndrome [J].
Coffler, MS ;
Patel, K ;
Dahan, MH ;
Malcom, PJ ;
Kawashima, T ;
Deutsch, R ;
Chang, RJ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (04) :1742-1747
[10]   Insulin resistance differentially affects the PI3-kinase- and MAP kinase-mediated signaling in human muscle [J].
Cusi, K ;
Maezono, K ;
Osman, A ;
Pendergrass, M ;
Patti, ME ;
Pratipanawatr, T ;
DeFronzo, RA ;
Kahn, CR ;
Mandarino, LJ .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (03) :311-320